Pharmacodynamics and pharmacokinetics related gene polymorphisms affect adverse drug reactions of haloperidol

被引：2
|
作者：
Zastrozhin, M. [1 ]
Sychev, D. [2 ]
Baymeeva, N. [3 ]
Miroshnichenko, I. [3 ]
Grishina, E. [4 ]
Bryun, E. [5 ]
机构：
[1] Minist Hlth Russian Federat, Russian Med Acad Postgrad Educ, Addictol, Moscow, Russia
[2] Minist Hlth Russian Federat, Russian Med Acad Postgrad Educ, Clin Pharmacol, Moscow, Russia
[3] Mental Hlth Res Ctr, Lab Pharmacokinet, Moscow, Russia
[4] Minist Hlth Russian Federat, Russian Med Acad Postgrad Educ, Lab Mol Res, Moscow, Russia
[5] Moscow Dept Healthcare, Moscow Res & Pract Ctr Addict, Addictol, Moscow, Russia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2018年 / 28卷
关键词：
TARDIVE-DYSKINESIA;
D O I：
10.1016/j.euroneuro.2017.12.021
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.1.003
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [1] Pharmacodynamic and pharmacokinetic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-related psychosis
    Zastrozhin, M.
    [J]. EUROPEAN PSYCHIATRY, 2018, 48 : S201 - S202
  • [2] Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder
    Zastrozhin, Mikhail Sergeevich
    Brodyansky, Vadim Markovich
    Skryabin, Valentin Yurievich
    Grishina, Elena Anatolievna
    Ivashchenko, Dmitry Vladimirovich
    Ryzhikova, Kristina Anatolievna
    Savchenko, Ludmila Mikhaylovna
    Kibitov, Alexander Olegovich
    Bryun, Evgeny Alekseevich
    Sychev, Dmitry Alekseevich
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 : 209 - 215
  • [3] RANITIDINE - PHARMACODYNAMICS, PHARMACOKINETICS AND ADVERSE REACTIONS
    SERLIN, MJ
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 1982, 45 (5-6): : 248 - 248
  • [4] The effect of diabetes mellitus on pharmacokinetics, pharmacodynamics and adverse drug reactions of anticancer drugs
    Mashayekhi-Sardoo, Habibeh
    Mohammadpour, Amir Hooshang
    Nomani, Homa
    Sahebkar, Amirhossein
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 19339 - 19351
  • [5] Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Herrador, Coral
    Belmonte, Carmen L.
    Roman, Manuel
    Alday, Enrique
    Koller, Dora
    Zubiaur, Pablo
    Mejia, Gina
    Hernandez-Martinez, Maria
    Abad-Santos, Francisco
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (03) : 321 - 329
  • [6] Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis
    Zhang, Ling Ling
    Yang, Sen
    Wei, Wei
    Zhang, Xue Jun
    [J]. PHARMACOGENETICS AND GENOMICS, 2014, 24 (11): : 531 - 538
  • [7] Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy
    Lu, Jin
    Wang, Xiuzhe
    Wan, Lili
    Fu, Jianliang
    Huo, Yan
    Zhao, Yuwu
    Guo, Cheng
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [8] IMPACT OF GENE POLYMORPHISMS ON PHARMACOKINETICS AND PHARMACODYNAMICS OF OLANZAPINE AND CLOZAPINE
    Dahl, M-L.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [9] The pharmacology of blinatumomab: state of the art on pharmacodynamics, pharmacokinetics, adverse drug reactions and evaluation in clinical trials
    Mocquot, Pauline
    Mossazadeh, Yasmine
    Lapierre, Leopoldine
    Pineau, Fanny
    Despas, Fabien
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (09) : 1337 - 1351
  • [10] Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy
    Gentile, Giovanna
    Borro, Marina
    Simmaco, Maurizio
    Missori, Serena
    Lala, Noemi
    Martelletti, Paolo
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (01) : 39 - 47
12345